Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 12-week, multi-center,randomized, double-blind, placebo-controlled efficacy and safety study examining seizure frequency of BGG492 capsules administration orally three times daily (TID) as adjunctive treatment in patients with partial onset seizures https://kusajili.com:443/Trial/szntno1xmkuc8aO7HVuxvg%24a-12-week-multi-centerrandomized-double-blind-placebo-controlled-efficacy-and-safety-study-examining-seizure-frequency-of-bgg49
I have read and accept the terms of use of the site and the Privacy Policy
Send your message